Obermatt

SKAN

SWX:SKAN · CH0013396012
Life Sciences Tools & ServicesSmall

360

61
EV / EBIT19
Price / Owner Earnings94
Owner Earnings Yield1
Dividend Yield39
Price/Sales36
EV / Gross Profit91
Price/Book10
Return on Capital80
Cash Return on Capital43
Return on Equity84
EBIT Margin59
Gross Profitability96
Cash Conversion83
Accruals1
Owner Earnings Margin50
Sales growth96
Profit Growth25
Long-Term EPS Growth5
Reinvestment4
Price momentum13
Debt load16
Refinancing12
Debt Payback1
Liquidity86
Analyst ratings100
Opinion Changes50
Price Target Upside59
Market mood100
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

SKAN clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySwitzerland
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeSWX
Founded1997
Employees0
ISINCH0013396012
Last UpdateApr 2, 2026
Themes
Environment, Health and Safety (EH&S)

Description

SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries. Business Segments The company operates through aseptic production equipment, service and support division, research and d…

Analysis

Middle-of-the-road

SKAN Group AG is a middle-of-the-road business: neither the economics nor the price stand out from the peer group. One caution: reported profits have recently run ahead of actual cash, which we track closely.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 10/20 on our value-creation score: creating some value.

What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
14
2023202420252026

All-time high

91

Jan 2024

All-time low

6

Mar 2026

Average rank

53

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
36
49
45
50
Price/Earnings
13
10
7
6
Price/Book
10
3
1
7
Dividend Yield
39
25
27
23
Value (overall)
17
6
8
8

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare SKAN with its peers
RHI Magnesita
LSE:RHIM
60
CountryAustria
IndustryConstruction Materials
SizeLarge
Full Stock Analysis →
Jenoptik
GER:JEN
74
CountryGermany
IndustryElectronic Equipment, Instruments & Components
SizeMedium
Full Stock Analysis →
Vend Marketplaces
OSL:VEND
5
CountryNorway
IndustryInteractive Media & Services
SizeLarge
Full Stock Analysis →
Solvay
BRU:SOLB
14
CountryBelgium
IndustryChemicals
SizeLarge
Full Stock Analysis →
Bodycote
LSE:BOY
81
CountryUK
IndustryMachinery
SizeMedium
Full Stock Analysis →
Sectra
STO:SECT B
65
CountrySweden
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →